Psychometric Properties of the Patient Health Questionnaire-9 in Patients With Heart Failure and an Implantable

Islam M Alhusban1, Debra K Moser2, Martha Biddle3

  • 1Islam M. Alhusban, MSN, RN, PhD, College of Nursing, University of Kentucky, Lexington, Kentucky.

Insights

The Patient Health Questionnaire-9 (PHQ-9) is a reliable tool for measuring depression in heart failure (HF) patients with implantable cardioverter defibrillators (ICDs). This validated instrument aids in diagnosing and managing depressive symptoms in this vulnerable population.

Area of Science:

  • Cardiology
  • Psychiatry
  • Medical Devices

Background:

  • Depressive symptoms are common in heart failure (HF) patients with implantable cardioverter defibrillators (ICDs).
  • Undiagnosed depression negatively impacts patient health outcomes.
  • A reliable measurement tool is crucial for this population.

Purpose of the Study:

  • To evaluate the psychometric properties of the Patient Health Questionnaire-9 (PHQ-9).
  • To assess the reliability and validity of the PHQ-9 in patients with HF and ICDs.

Main Methods:

  • Secondary analysis of data from 258 patients with HF and ICDs.
  • Assessed internal consistency using Cronbach's alpha.
  • Evaluated construct validity through hypothesis testing and convergent validity.
  • Determined dimensionality using exploratory factor analysis.

Main Results:

  • PHQ-9 demonstrated strong internal consistency (Cronbach's alpha = 0.85).
  • Scores correlated significantly with HF symptom severity and anxiety levels.
  • Convergent validity was supported by a strong correlation with the Minnesota Living with Heart Failure scale (r = 0.73).
  • Exploratory factor analysis confirmed a single-factor structure explaining 47.29% of the variance.

Conclusions:

  • The PHQ-9 is a reliable and valid measure for depressive symptoms in patients with HF and ICDs.
  • Findings support the use of PHQ-9 for clinical assessment and research in this population.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.0K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
539
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
648
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
627
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
725